BCM
TECX

Burrage Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Burrage Capital Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,410
Closed -$2.18M – 19
2021
Q2 		$2.18M Hold
20,410
– – 2.18% 18
2021
Q1 		$3.11M Buy
20,410
+8,267
+68% +$1.34M 2.52% 20
2020
Q4 		$2.03M Buy
+12,143
New +$2.16M 1.55% 23
2020
Q3 		– Sell
-18,825
Closed -$3.94M – 29
2020
Q2 		$3.94M Hold
18,825
– – 2.76% 20
2020
Q1 		$3.27M Buy
+18,825
New +$4.43M 3.22% 15

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Burrage Capital Management's TECX Position: Q3 2021 in Review

Burrage Capital Management sold out of Tectonic Therapeutic (TECX) in Q3 2021, closing a stake of 20,410 shares — an estimated $2.18M sold.

Burrage Capital Management first reported a position in TECX in Q1 2020 and held it in 5 quarters. The position peaked at $3.94M in Q2 2020. 99 funds tracked by Wall St. Rank hold TECX as of Q3 2021.

  • Burrage Capital Management reported no remaining Tectonic Therapeutic position as of Q3 2021 after selling out during the quarter.
  • Burrage Capital Management sold 20,410 Tectonic Therapeutic shares in Q3 2021, an estimated $2.18M.
  • Burrage Capital Management first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 5 quarters.
  • Burrage Capital Management's Tectonic Therapeutic position peaked at $3.94M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.